Nuala
Chief Operational Officer
Icon
Ireland
Biography
Dr. Nuala Murphy has been President of ICON Clinical Services at ICON since January 2014. Prior to this, Dr. Murphy served as Executive Vice President of clinical and data operations globally. Dr. Murphy has over 20 years’ experience within the pharmaceutical and CRO industry. Dr. Murphy joined ICON in 2012 from Quintiles where she led a clinical and data management workforce (since 2009). Dr. Murphy also has over a decade of experience in therapeutics having led the CNS and internal medicine project management divisions for Quintiles. Dr. Murphy served in the field of late phase clinical research at Benefit International. During her tenure, Dr. Murphy published extensively in eminent peer reviewed journals. Having graduated from Trinity College Dublin, Dr. Murphy was awarded a PhD in neurochemistry, from the Department of Cardiovascular Studies in Leeds and conducted post-doctoral research in the Department of Neuropharmacology at the Collège de France in Paris. Dr. Nuala Murphy has been President of ICON Clinical Services at ICON since January 2014. Prior to this, Dr. Murphy served as Executive Vice President of clinical and data operations globally. Dr. Murphy has over 20 years’ experience within the pharmaceutical and CRO industry. Dr. Murphy joined ICON in 2012 from Quintiles where she led a clinical and data management workforce (since 2009). Dr. Murphy also has over a decade of experience in therapeutics having led the CNS and internal medicine project management divisions for Quintiles. Dr. Murphy served in the field of late phase clinical research at Benefit International. During her tenure, Dr. Murphy published extensively in eminent peer reviewed journals. Having graduated from Trinity College Dublin, Dr. Murphy was awarded a PhD in neurochemistry, from the Department of Cardiovascular Studies in Leeds and conducted post-doctoral research in the Department of Neuropharmacology at the Collège de France in Paris.
Research Interest
clinical, consulting and commercial services that range from trial design to full study execution, and from clinical to post-market commercialisation.
